Combination Therapy Enhances Stem Cell Mobilization in Patients With Multiple Myeloma

A phase III trial evaluated intermediate-dose cytarabine plus  granulocyte-colony stimulating factor (G-CSF) vs G-CSF alone prior to autoSCT in multiple myeloma.

Source: CancerNetwork - April 16, 2019 Category: Cancer & Oncology Authors: Lauren M. Dembeck, PhD Source Type: news